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The authors of the above mentioned paper
would like to make the following correction to
the author list.
Laura Ordon˜ez-Boschetti  Roberto Rey  Ana
Cruz  Arijit Sinha  Tracy Reynolds  Nadina
Frider  Regina Alvarenga
The original article has been updated
accordingly.
Open Access. This article is distributed
under the terms of the Creative Commons
Attribution Noncommercial License which
permits any noncommercial use, distribution,
and reproduction in any medium, provided the
original author(s) and the source are credited.
The online version of the original article can be found
under doi:10.1007/s12325-015-0224-2.
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